| Disease | Target Count | P-value |
|---|---|---|
| breast carcinoma | 1638 | 7.2e-42 |
| Breast cancer | 3578 | 3.1e-38 |
| psoriasis | 6694 | 6.5e-24 |
| ovarian cancer | 8520 | 5.8e-14 |
| invasive ductal carcinoma | 2951 | 2.5e-05 |
| group 4 medulloblastoma | 1855 | 1.2e-04 |
| pediatric high grade glioma | 1064 | 1.3e-04 |
| osteosarcoma | 7950 | 1.7e-04 |
| medulloblastoma, large-cell | 6241 | 2.5e-04 |
| ductal carcinoma in situ | 1745 | 5.3e-04 |
| atypical teratoid / rhabdoid tumor | 5112 | 3.1e-03 |
| pituitary cancer | 1972 | 4.0e-03 |
| glioblastoma | 5792 | 4.4e-03 |
| astrocytic glioma | 2597 | 4.8e-03 |
| ependymoma | 4679 | 5.9e-03 |
| oligodendroglioma | 2850 | 9.4e-03 |
| primitive neuroectodermal tumor | 3035 | 1.1e-02 |
| intraductal papillary-mucinous carcinoma (IPMC) | 2989 | 2.5e-02 |
| Disease | log2 FC | p |
|---|---|---|
| astrocytic glioma | -2.900 | 4.8e-03 |
| atypical teratoid / rhabdoid tumor | -1.600 | 3.1e-03 |
| Breast cancer | -2.900 | 3.1e-38 |
| breast carcinoma | -1.500 | 7.2e-42 |
| ductal carcinoma in situ | -1.700 | 5.3e-04 |
| ependymoma | -3.700 | 5.9e-03 |
| glioblastoma | 1.300 | 4.4e-03 |
| group 4 medulloblastoma | -2.400 | 1.2e-04 |
| intraductal papillary-mucinous carcinoma... | -1.200 | 2.5e-02 |
| invasive ductal carcinoma | -2.400 | 2.5e-05 |
| medulloblastoma, large-cell | 1.700 | 2.5e-04 |
| oligodendroglioma | -3.300 | 9.4e-03 |
| osteosarcoma | 2.270 | 1.7e-04 |
| ovarian cancer | -3.200 | 5.8e-14 |
| pediatric high grade glioma | 1.200 | 1.3e-04 |
| pituitary cancer | 1.100 | 4.0e-03 |
| primitive neuroectodermal tumor | -1.400 | 1.1e-02 |
| psoriasis | -1.100 | 6.5e-24 |
